DROPPING TODAY Biotechnology $319M Cap Quant: HOLD

Why Is Editas Medicine, Inc. (EDIT) Stock Down Today?

Updated Nov 16, 2026 8:00 PM ET · Prev Close $2.17

Pro Workspace
Last Session Price
$1.91 -12.21%
-$0.26 vs $2.17 prior close
Intraday Range
$1.90 – $2.12
Open $2.10
Relative Volume
0.58x Avg
1,301,046 sh
52-Week Range
$1.66 – $3.94
Benchmark Alpha
-10.32% vs SPY
-9.79% vs QQQ
20-Session Trend -26.2%

Primary Move Catalyst & Conviction

65% Signal Conviction
SECTOR 65% Driver Weight

Biotechnology & Biological Products sector moving together

This appears to be a sector-wide move. The Biotechnology & Biological Products sector is down 3.2% on average.

Volume Confirmation
LOW VOLUME (0.58x) Unconfirmed
Sub-average participation — monitor RVOL expansion above 1.2x.
Composite Catalyst Confidence 65%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

EDIT lagging the S&P 500 by -10.32%
EDIT Session
-12.21%
$1.91
S&P 500 (SPY)
-1.89%
$740.11
Nasdaq 100 (QQQ)
-2.42%
$663.44
Healthcare (XLV)
-0.38%
$188.14
Alpha vs SPY: -10.32% Alpha vs QQQ: -9.79% Alpha vs XLV: -11.83%
Peer Group: Biotechnology & Biological Products (-3.2% avg) Lagging peers by -9.0%

Options Flow & Execution Desk

Bullish Flow · P/C 0.63
Call Volume
11,751
Contracts
Put Volume
7,368
Contracts
Put / Call Ratio
0.63
19,119 total vol
Implied Volatility
118.8%
Chain avg IV
TRADESTIE PRO DESK 2 Unusual Contract Sweeps

Unlock 2 Strike-Verified Options Setups for EDIT

Our options desk modeled ATM Call Rebound / Continuation, ATM Put Downside Positioning structures for the Dec 18 expiration cycle, plus live unusual contract strike sweeps and full factor sub-scores.

Recent EDIT Catalyst Headlines

Verified Wire
Editas Q3 Earnings Snapshot

EDIT on Monday reported a loss of 23.On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 15 cents.

Yahoo Finance · Nov 09, 2026

1–3 Day Expected Range & Key Level

35% Follow-Through
Lower Bound
$1.85
Short-term support band
Upper Bound
$1.94
Short-term resistance band
Key Inflection Level
$1.81 (support)

Watch for breakdown below $1.91

Technical Regime (EDIT)

BEARISH MA TREND
RSI (14)
35.1
Bearish
20-Day SMA
$2.52
Below 20d
50-Day SMA
$2.61
Below 50d
MACD Signal
Bearish
MACD -0.12
ADX (14)
13.5
Weak trend
10d Momentum
-0.57
Soft 10-day momentum

1-Year Historical Move Analogs

70 Events

Sessions in the past year where EDIT moved >3.0% down:

Continuation Rate
44.3%
31/70 sessions
Avg Next-Day Move
-0.27%
T+1 session return
Last analog: Nov 12, 2026 (-10.1%) → Next session: +1.4%

Retail & Crowd Sentiment

Very Bullish
24h Messages
2
1.2x 7d avg
Bullish / Bearish
100.0% / 0.0%
Low buzz
Crowd Discussion Digest

StockTwits shows bullish sentiment towards $EDIT, with one user expecting a rebound after hours and a potential upward trend come Monday.

About Editas Medicine, Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short pali...

Sector
Healthcare
Market Cap
$319M
Employees
226

Get Instant EDIT Catalyst Alerts

Receive an email alert when EDIT triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

EDIT Session & Catalyst FAQ

Why is EDIT stock down today?

This appears to be a sector-wide move. The Biotechnology & Biological Products sector is down 3.2% on average.

Is EDIT stock a buy or sell right now?

Today's session carries a 65% catalyst conviction score on 0.58x relative volume (low participation). Our multi-factor model currently rates EDIT as HOLD. Review full valuation, quality, and timing signals on the EDIT Buy or Sell Decision Brief →

What is EDIT's intrinsic value and expected trading range?

At $1.91, EDIT's modeled 1-to-3 session range is $1.85 – $1.94, with a key inflection level at $1.81 (support). Compare current price against multi-year cash flow projections in the EDIT Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for EDIT?

RSI at 35.1 reflects soft below-midline momentum. EDIT trades at $1.91 relative to its 20-day SMA ($2.52) and 50-day SMA ($2.61), reflecting a bearish moving-average structure.

Tradestie Flagship Research & Market Hubs